» Articles » PMID: 38401046

NRF2 Deficiency Promotes Ferroptosis of Astrocytes Mediated by Oxidative Stress in Alzheimer's Disease

Overview
Journal Mol Neurobiol
Date 2024 Feb 24
PMID 38401046
Authors
Affiliations
Soon will be listed here.
Abstract

Oxidative stress is involved in the pathogenesis of Alzheimer's disease (AD), which is linked to reactive oxygen species (ROS), lipid peroxidation, and neurotoxicity. Emerging evidence suggests a role of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a major source of antioxidant response elements in AD. The molecular mechanism of oxidative stress and ferroptosis in astrocytes in AD is not yet fully understood. Here, we aimed to investigate the mechanism by which Nrf2 regulates the ferroptosis of astrocytes in AD. We found decreased expression of Nrf2 and upregulated expression of the ROS marker NADPH oxidase 4 (NOX4) in the frontal cortex from patients with AD and in the cortex of 3×Tg mice compared to wildtype mice. We demonstrated that Nrf2 deficiency led to ferroptosis-dependent oxidative stress-induced ROS with downregulated heme oxygenase-1 and glutathione peroxidase 4 and upregulated cystine glutamate expression. Moreover, Nrf2 deficiency increased lipid peroxidation, DNA oxidation, and mitochondrial fragmentation in mouse astrocytes (mAS, M1800-57). In conclusion, these results suggest that Nrf2 deficiency promotes ferroptosis of astrocytes involving oxidative stress in AD.

Citing Articles

Role of NRF2 in Pathogenesis of Alzheimer's Disease.

Chu C, Uruno A, Katsuoka F, Yamamoto M Antioxidants (Basel). 2025; 13(12.

PMID: 39765857 PMC: 11727090. DOI: 10.3390/antiox13121529.


Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention.

Goncalves M, Costa M, Paiva-Martins F, Silva P Molecules. 2024; 29(20).

PMID: 39459209 PMC: 11510978. DOI: 10.3390/molecules29204841.


Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.

Qiu M, Ma K, Zhang J, Zhao Z, Wang S, Wang Q Front Pharmacol. 2024; 15:1395735.

PMID: 39444605 PMC: 11496173. DOI: 10.3389/fphar.2024.1395735.


Iron homeostasis and ferroptosis in human diseases: mechanisms and therapeutic prospects.

Ru Q, Li Y, Chen L, Wu Y, Min J, Wang F Signal Transduct Target Ther. 2024; 9(1):271.

PMID: 39396974 PMC: 11486532. DOI: 10.1038/s41392-024-01969-z.


Vitamin D Attenuates Neuropathic Pain via Suppression of Mitochondria-Associated Ferroptosis by Inhibiting PKCα/NOX4 Signaling Pathway.

Zhang W, Yu S, Jiao B, Zhang C, Zhang K, Liu B CNS Neurosci Ther. 2024; 30(9):e70067.

PMID: 39328008 PMC: 11427799. DOI: 10.1111/cns.70067.


References
1.
De Strooper B, Karran E . The Cellular Phase of Alzheimer's Disease. Cell. 2016; 164(4):603-15. DOI: 10.1016/j.cell.2015.12.056. View

2.
Wilson 3rd D, Cookson M, Van Den Bosch L, Zetterberg H, Holtzman D, Dewachter I . Hallmarks of neurodegenerative diseases. Cell. 2023; 186(4):693-714. DOI: 10.1016/j.cell.2022.12.032. View

3.
Brandebura A, Paumier A, Onur T, Allen N . Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders. Nat Rev Neurosci. 2022; 24(1):23-39. PMC: 10198620. DOI: 10.1038/s41583-022-00641-1. View

4.
Escartin C, Galea E, Lakatos A, OCallaghan J, Petzold G, Serrano-Pozo A . Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021; 24(3):312-325. PMC: 8007081. DOI: 10.1038/s41593-020-00783-4. View

5.
Hasel P, Rose I, Sadick J, Kim R, Liddelow S . Neuroinflammatory astrocyte subtypes in the mouse brain. Nat Neurosci. 2021; 24(10):1475-1487. DOI: 10.1038/s41593-021-00905-6. View